Health Catalyst (HCAT) News Today $5.23 -0.16 (-2.97%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$5.26 +0.03 (+0.55%) As of 02/21/2025 05:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Health Catalyst, Inc. (NASDAQ:HCAT) Insider Linda Llewelyn Sells 6,441 SharesHealth Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) insider Linda Llewelyn sold 6,441 shares of Health Catalyst stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $5.43, for a total transaction of $34,974.63. Following the completion of the transaction, the insider now directly owns 85,819 shares of the company's stock, valued at approximately $465,997.17. This represents a 6.98 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.February 21 at 8:51 PM | marketbeat.comHealth Catalyst (HCAT) Expected to Announce Earnings on WednesdayHealth Catalyst (NASDAQ:HCAT) will be releasing earnings after the market closes on Wednesday, February 26. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=662662)February 19 at 5:19 AM | marketbeat.comHealth Catalyst to Participate in Upcoming Investor ConferenceFebruary 18, 2025 | globenewswire.comMartin & Co. Inc. TN Has $3.47 Million Stake in Health Catalyst, Inc. (NASDAQ:HCAT)Martin & Co. Inc. TN increased its stake in shares of Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 80.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 490,998 shares of the company's stock afteFebruary 17, 2025 | marketbeat.comHealth Catalyst, Inc. (NASDAQ:HCAT) Short Interest UpdateHealth Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) saw a large decrease in short interest in the month of January. As of January 31st, there was short interest totalling 2,010,000 shares, a decrease of 21.5% from the January 15th total of 2,560,000 shares. Based on an average daily volume of 656,600 shares, the days-to-cover ratio is currently 3.1 days.February 16, 2025 | marketbeat.comPiper Sandler cuts Health Catalyst price target to $8, keeps overweightFebruary 11, 2025 | msn.comHealth Catalyst price target lowered to $8 from $12 at Piper SandlerFebruary 11, 2025 | markets.businessinsider.comHealth Catalyst (NASDAQ:HCAT) Price Target Lowered to $8.00 at Piper SandlerPiper Sandler dropped their price target on shares of Health Catalyst from $12.00 to $8.00 and set an "overweight" rating for the company in a research note on Tuesday.February 11, 2025 | marketbeat.comHealth Catalyst, Inc. (NASDAQ:HCAT) Shares Sold by Janney Montgomery Scott LLCJanney Montgomery Scott LLC trimmed its holdings in Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 55.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 49,496 shares of the company's stock after sellingFebruary 11, 2025 | marketbeat.comHealth Catalyst, Inc. (NASDAQ:HCAT) Given Average Recommendation of "Moderate Buy" by BrokeragesShares of Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) have earned a consensus rating of "Moderate Buy" from the ten analysts that are covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a hold recommendation and eight have given a buy recommeFebruary 8, 2025 | marketbeat.comHealth Catalyst COO sells $30,007 in stockFebruary 7, 2025 | msn.comHealth Catalyst, Inc. (NASDAQ:HCAT) COO Daniel Lesueur Sells 5,209 SharesFebruary 7, 2025 | insidertrades.comHealth Catalyst, Inc. (NASDAQ:HCAT) COO Sells $30,003.84 in StockHealth Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) COO Daniel Lesueur sold 5,209 shares of the firm's stock in a transaction on Wednesday, February 5th. The shares were sold at an average price of $5.76, for a total transaction of $30,003.84. Following the transaction, the chief operating officer now directly owns 86,044 shares of the company's stock, valued at $495,613.44. The trade was a 5.71 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.February 6, 2025 | marketbeat.comHealth Catalyst to Participate in Upcoming Investor ConferenceJanuary 30, 2025 | globenewswire.comHealth-Tech Revival: 3 Stocks Set for a Big 2025 Rebound (HCAT)Check out these three health-tech stocks with prospects of recovery in 2025 after seeing shares decline significantly in 2024.January 27, 2025 | marketbeat.comNepsis Inc. Reduces Holdings in Health Catalyst, Inc. (NASDAQ:HCAT)Nepsis Inc. decreased its stake in shares of Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 95.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 96,257 shares of the company's stock after selling 2,January 25, 2025 | marketbeat.comWith 87% ownership of the shares, Health Catalyst, Inc. (NASDAQ:HCAT) is heavily dominated by institutional ownersJanuary 24, 2025 | uk.finance.yahoo.comWinners And Losers Of Q3: Health Catalyst (NASDAQ:HCAT) Vs The Rest Of The Data Analytics StocksJanuary 22, 2025 | finance.yahoo.comWells Fargo Remains a Buy on Health Catalyst (HCAT)January 21, 2025 | markets.businessinsider.comHealth Catalyst price target lowered to $10 from $11 at CanaccordJanuary 21, 2025 | markets.businessinsider.comHealth Catalyst stock target cut, buy rating at Canaccord on developmentsJanuary 21, 2025 | msn.comWells Fargo & Company Lowers Health Catalyst (NASDAQ:HCAT) Price Target to $10.00Wells Fargo & Company lowered their target price on shares of Health Catalyst from $13.00 to $10.00 and set an "overweight" rating on the stock in a research note on Tuesday.January 21, 2025 | marketbeat.comHealth Catalyst (NASDAQ:HCAT) Given New $10.00 Price Target at Canaccord Genuity GroupCanaccord Genuity Group decreased their price target on Health Catalyst from $11.00 to $10.00 and set a "buy" rating for the company in a research note on Tuesday.January 21, 2025 | marketbeat.comLinda Llewelyn Sells 6,442 Shares of Health Catalyst, Inc. (NASDAQ:HCAT) StockJanuary 18, 2025 | insidertrades.comHealth Catalyst chief people officer sells $37,348 in stockJanuary 17, 2025 | msn.comHealth Catalyst, Inc. (NASDAQ:HCAT) Insider Sells $37,363.60 in StockHealth Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) insider Linda Llewelyn sold 6,442 shares of the stock in a transaction dated Wednesday, January 15th. The shares were sold at an average price of $5.80, for a total transaction of $37,363.60. Following the completion of the transaction, the insider now owns 92,260 shares of the company's stock, valued at $535,108. This represents a 6.53 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.January 17, 2025 | marketbeat.comStifel Nicolaus Remains a Hold on Health Catalyst (HCAT)January 17, 2025 | markets.businessinsider.comHealth Catalyst stock hits 52-week low at $5.4 amid market challengesJanuary 17, 2025 | msn.comEvercore ISI Reaffirms Their Buy Rating on Health Catalyst (HCAT)January 17, 2025 | markets.businessinsider.comRoyal Bank of Canada Issues Pessimistic Forecast for Health Catalyst (NASDAQ:HCAT) Stock PriceRoyal Bank of Canada dropped their price objective on shares of Health Catalyst from $9.00 to $7.00 and set a "sector perform" rating for the company in a research report on Wednesday.January 16, 2025 | marketbeat.comHealth Catalyst price target lowered to $7 from $9 at RBC CapitalJanuary 15, 2025 | markets.businessinsider.comHealth Catalyst, Inc. (NASDAQ:HCAT) Receives Average Recommendation of "Moderate Buy" from AnalystsShares of Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) have earned an average rating of "Moderate Buy" from the eleven research firms that are currently covering the company, Marketbeat.com reports. Two analysts have rated the stock with a hold recommendation and nine have issued a buy reJanuary 14, 2025 | marketbeat.comOrthoNebraska Selects Health Catalyst Ignite(TM) to Advance Data-Driven Orthopedic CareJanuary 13, 2025 | stockhouse.comHealth Catalyst Signs Definitive Agreement to Acquire Upfront Healthcare ServicesJanuary 13, 2025 | prnewswire.comHealth Catalyst Recognized as a Leader in Frost & Sullivan's 2024 US Population Health Management ReportJanuary 13, 2025 | prnewswire.comHealth Catalyst Partners with Databricks to Elevate Next-Gen Healthcare Data Sharing and AnalyticsJanuary 13, 2025 | prnewswire.comOrthoNebraska Selects Health Catalyst Ignite™ to Advance Data-Driven Orthopedic CareJanuary 13, 2025 | prnewswire.comHealth Catalyst, Inc. (NASDAQ:HCAT) General Counsel Sells $18,800.00 in StockJanuary 11, 2025 | insidertrades.comBenjamin Landry Sells 2,500 Shares of Health Catalyst, Inc. (NASDAQ:HCAT) StockHealth Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) General Counsel Benjamin Landry sold 2,500 shares of the business's stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $7.52, for a total value of $18,800.00. Following the sale, the general counsel now directly owns 72,250 shares of the company's stock, valued at $543,320. This represents a 3.34 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link.January 10, 2025 | marketbeat.comInsider Selling: Health Catalyst, Inc. (NASDAQ:HCAT) COO Sells 5,209 Shares of StockHealth Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) COO Daniel Lesueur sold 5,209 shares of the business's stock in a transaction that occurred on Monday, January 6th. The shares were sold at an average price of $7.51, for a total value of $39,119.59. Following the completion of the sale, the chief operating officer now directly owns 91,253 shares of the company's stock, valued at approximately $685,310.03. The trade was a 5.40 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link.January 10, 2025 | marketbeat.comHealth Catalyst price target lowered to $10 from $10.50 at CitiJanuary 10, 2025 | markets.businessinsider.comCitigroup Lowers Health Catalyst (NASDAQ:HCAT) Price Target to $10.00Citigroup lowered their price target on shares of Health Catalyst from $10.50 to $10.00 and set a "buy" rating for the company in a report on Friday.January 10, 2025 | marketbeat.comHealth Catalyst (NASDAQ:HCAT) Upgraded by KeyCorp to "Overweight" RatingKeyCorp upgraded Health Catalyst from a "sector weight" rating to an "overweight" rating and set a $9.00 price target for the company in a research note on Wednesday.January 8, 2025 | marketbeat.comHealth Catalyst upgraded to Overweight from Sector Weight at KeyBancJanuary 8, 2025 | markets.businessinsider.comHealth Catalyst, Inc. (NASDAQ:HCAT) Director Sells $31,185.00 in StockJanuary 3, 2025 | insidertrades.comInsider Selling: Health Catalyst, Inc. (NASDAQ:HCAT) Director Sells 4,500 Shares of StockHealth Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) Director Duncan Gallagher sold 4,500 shares of the firm's stock in a transaction dated Monday, December 30th. The stock was sold at an average price of $6.93, for a total value of $31,185.00. Following the completion of the transaction, the director now owns 69,938 shares in the company, valued at approximately $484,670.34. This trade represents a 6.05 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.January 2, 2025 | marketbeat.comHealth Catalyst, Inc. (NASDAQ:HCAT) Given Average Rating of "Moderate Buy" by BrokeragesHealth Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the twelve analysts that are presently covering the company, Marketbeat.com reports. Three analysts have rated the stock with a hold recommendation and nine have issued a buy recommDecember 20, 2024 | marketbeat.comInsider Selling: Health Catalyst, Inc. (NASDAQ:HCAT) Insider Sells 6,442 Shares of StockHealth Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) insider Linda Llewelyn sold 6,442 shares of the business's stock in a transaction dated Monday, December 16th. The stock was sold at an average price of $7.88, for a total transaction of $50,762.96. Following the sale, the insider now directly owns 98,702 shares in the company, valued at approximately $777,771.76. This represents a 6.13 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.December 18, 2024 | marketbeat.comHealth Catalyst: Improved Demand Environment Reinforces My Buy RatingDecember 18, 2024 | seekingalpha.comInsider Selling: Health Catalyst, Inc. (NASDAQ:HCAT) General Counsel Sells 19,268 Shares of StockDecember 11, 2024 | insidertrades.com Get Health Catalyst News Delivered to You Automatically Sign up to receive the latest news and ratings for HCAT and its competitors with MarketBeat's FREE daily newsletter. Email Address HCAT Media Mentions By Week HCAT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HCAT News Sentiment▼0.750.60▲Average Medical News Sentiment HCAT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HCAT Articles This Week▼54▲HCAT Articles Average Week Get Health Catalyst News Delivered to You Automatically Sign up to receive the latest news and ratings for HCAT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies DCBO News WEAV News VTEX News TBLA News MOMO News AMPL News FSLY News VMEO News QUBT News KIND News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HCAT) was last updated on 2/22/2025 by MarketBeat.com Staff From Our Partners[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Health Catalyst, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Health Catalyst With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
